1. Role of Toll‑like receptors in natural killer cell function in acute lymphoblastic leukemia (Review)
   Janet Gallardo‑Zapata et al, 2021, Oncology Letters CrossRef
2. Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukaemia and its association with antibiotics in the short term
   Lu Bai et al, 2017, Journal of Medical Microbiology CrossRef
3. Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
   Ling Bai et al, 2017, Journal of Translational Medicine CrossRef
4. BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
   Ling Bai et al, 2023, Journal of Translational Medicine CrossRef
5. References
   Claudio Ortolani, 2021, Flow Cytometry of Hematological Malignancies CrossRef
6. Evaluation of NFKB1 and MyD88 expression levels in a sample of non-Hodgkin lymphoma patients before and during chemotherapy
   Eman Rashwan et al, 2024, Egyptian Journal of Basic and Applied Sciences CrossRef
7. NK Cell Subpopulation Is Altered and the Expression of TLR1 and TLR9 Is Decreased in Patients with Acute Lymphoblastic Leukemia
   David Sánchez-Herrera et al, 2021, Journal of Oncology CrossRef
8. The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
   Natasha Ustyanovska Avtenyuk et al, 2020, International Journal of Molecular Sciences CrossRef
9. Toll-like Receptors 2, 3, and 4 in Childhood Acute Lymphocytic Leukemia
   Matheus Loureiro da Silva Cruz et al, 2023, Revista Brasileira de Cancerologia CrossRef
10. Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias
    Kinga Panuciak et al, 2022, Cells CrossRef